Pulmatrix, Inc. (PULM)
1.48
+0.06
(+4.23%)
USD |
NASDAQ |
Oct 23, 16:00
1.46
-0.02
(-1.35%)
After-Hours: 20:00
Pulmatrix Net Income (Quarterly) : -1.036M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.036M |
| March 31, 2026 | -1.172M |
| December 31, 2025 | -0.928M |
| September 30, 2025 | -0.877M |
| June 30, 2025 | -1.549M |
| March 31, 2025 | -1.808M |
| December 31, 2024 | -1.986M |
| September 30, 2024 | -2.587M |
| June 30, 2024 | -5.811M |
| March 31, 2024 | 0.825M |
| December 31, 2023 | -2.083M |
| September 30, 2023 | -3.774M |
| June 30, 2023 | -3.816M |
| March 31, 2023 | -4.448M |
| December 31, 2022 | -4.216M |
| September 30, 2022 | -5.052M |
| June 30, 2022 | -4.595M |
| March 31, 2022 | -4.973M |
| December 31, 2021 | -4.031M |
| September 30, 2021 | -8.184M |
| June 30, 2021 | -3.852M |
| March 31, 2021 | -4.104M |
| December 31, 2020 | -2.899M |
| September 30, 2020 | -10.55M |
| June 30, 2020 | -1.17M |
| Date | Value |
|---|---|
| March 31, 2020 | -4.686M |
| December 31, 2019 | -4.041M |
| September 30, 2019 | -3.555M |
| June 30, 2019 | -7.844M |
| March 31, 2019 | -5.156M |
| December 31, 2018 | -4.338M |
| September 30, 2018 | -4.816M |
| June 30, 2018 | -6.188M |
| March 31, 2018 | -5.221M |
| December 31, 2017 | -4.524M |
| September 30, 2017 | -4.452M |
| June 30, 2017 | -5.597M |
| March 31, 2017 | -3.483M |
| December 31, 2016 | -9.83M |
| September 30, 2016 | -3.157M |
| June 30, 2016 | -9.187M |
| March 31, 2016 | -5.669M |
| December 31, 2015 | -4.536M |
| September 30, 2015 | -4.932M |
| June 30, 2015 | -14.90M |
| March 31, 2015 | -1.803M |
| March 31, 2014 | -0.989M |
| December 31, 2013 | -0.658M |
| September 30, 2013 | -0.994M |
| June 30, 2013 | -0.477M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.036M |
| EPS Diluted (Quarterly) | -0.288 |
| Enterprise Value | 3.503M |
| Earnings Yield | -74.53% |
| Normalized Earnings Yield | -74.53 |